Company Information
USD
8.54
- (-%)
NASDAQ:CMRX, CHIMERIX, INC.
Industry: Biotechnology
End of Day: 21 April 2025 GMT-4
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Address
2505 Meridian Parkway
Suite 100
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Patrick C. Machado, J.D.
Director
Ms. Martha J. Demski
Director
Mr. Fred A. Middleton
Director
Mr. Michael A. Sherman
Chairman of the Board/Director
Mr. Pratik S. Multani, M.D.
Director
Mr. Robert J. Meyer, M.D.
Director
Mr. Michael T. Andriole
CEO/Director/President
Mr. Thomas J. Riga
COO/Other Executive Officer
Mr. David Jakeman
Chief Accounting Officer/Vice President, Divisional
Ms. Lisa Lynn Decker, PhD
Director
Ms. Victoria Vakiener
Director
Ms. Michelle LaSpaluto
CFO
Mr. Allen S. Melemed
Chief Medical Officer
Ownership
Institution Holdings
RA Capital Management, LP
8,800,000 (9.900%)
RA Capital Management, LLC
8,800,000 (9.864%)
Rubric Capital Management LP
4,779,020 (5.376%)
Monaco Asset Management
4,377,674 (4.907%)
Vanguard Group Inc
4,345,579 (4.871%)
Vanguard Investments Australia Ltd
2,904,360 (3.256%)
Armistice Capital, LLC
2,598,000 (2.912%)
Citadel Advisors Llc
2,426,526 (2.720%)
Goldman Sachs Group Inc
2,359,066 (2.644%)
Acadian Asset Management LLC
1,882,832 (2.111%)
Individual Holdings
Mr. Michael T. Andriole
447,021 (0.503%)
Mr. Michael A. Sherman
233,413 (0.264%)
Mr. Fred A. Middleton
207,523 (0.234%)
Mr. David Jakeman
141,232 (0.159%)
Ms. Michelle LaSpaluto
110,999 (0.125%)
Mr. Allen S. Melemed
86,430 (0.097%)
Mr. Robert J. Meyer, M.D.
35,150 (0.040%)
Mr. Patrick C. Machado, J.D.
10,000 (0.022%)
Funds Holdings
Northern Small Cap Value Fund
480,410 (0.539%)
Fidelity Extended Market Index Fund
433,334 (0.486%)
A4Investments SICAV SIF ACCI Ilana
250,000 (0.280%)
BlackRock Extended Equity Market
192,424 (0.216%)
NT Ext Equity Mkt Idx Fd - DC - NL
58,059 (0.065%)
Spartan Extended Market Index Pool
33,751 (0.038%)
Extended Equity Market Fund M
23,792 (0.027%)
BlackRock U.S. Equity Market
20,898 (0.023%)
NT Quality Small Cap Value
18,857 (0.021%)
NT Col Qual SC Val Fd - NL
18,857 (0.021%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
